Success Stories: EB-1A Approval for Assistant Professor in Ohio in the Field of Health Outcomes Research

Client’s Testimonial:

Absolutely, I will highly recommend your team.


We Received Another EB1-A (Alien of Extraordinary Ability) Approval on April 23rd, 2014 for an Assistant Professor in the Field of Health Outcomes Research (Approval Notice)

General Field: Health Outcomes Research

Position at the Time of Case Filing: Assistant Professor

National Origin: India

Service Center: Nebraska Service Center (NSC)

State of Residence at the Time of Filing: Ohio

Approval Notice Date: April 23, 2014

Processing Time: 1 months, 30 days (including RFE response time, Premium Processing requested)

 


Case Summary:

In this case, the client that we had the pleasure of working with was an Assistant Professor from India in the field of health outcomes research.  His work had primarily focused on investigating the relationships between disease outcome, hospital characteristics, financial costs, and medical errors.  This work had resulted in at least 65 peer-reviewed scientific articles. At the time that his case was filed, these publications been cited at least 92 times by researchers around the world, indicating the major significance of his work.  He had also reviewed at least 84 manuscripts for distinctive, internationally-circulated journals in his field and had been elected to an editorial board.  In addition, he was a member of 2 associations in his field which demand outstanding achievement for membership and had commanded a high salary in relation to others in his field. The value of his work was confirmed in the following quote from an independent recommender, “[His] research, while using data specifically from the United States, is applicable to the medical field in any country and has distinguished him to the status of an internationally impactful scholar.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of health outcomes research, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 1 month and 30 days.